Nanomedicine in Ophthalmology: Principles and Clinical Applications

Bs Ngô Hữu Thế
6.11.26
Last Updated

Nanotechnology provides an important new set of tools for the diagnosis and treatment of ocular diseases, as reviewed in Ryan's Retina (7th Ed., 2022). Miniaturized devices, chip-based technologies, and nano-sized material and chemical assemblies are improving healthcare in the 21st century and affecting ophthalmology.

General Principles of Nanotechnology and Nanomedicine

Nanotechnology involves the creation and use of materials and devices on the scale of intracellular structures and molecules, typically <100 nm. An average man is 1.6 billion nanometers tall, while an erythrocyte is 7,000 nm wide and a strand of DNA is 2 nm wide. Nanomedicine aims for comprehensive monitoring, control, construction, repair, defense, and improvement of human biological systems at the molecular level. Key principles include biomimicry, size-driven biocompatibility, feedback control, and the use of molecules as machines. Nanomachines are highly efficient and can be produced by assembling naturally occurring ones or using microelectromechanical systems (MEMS) and nanoelectromechanical systems (NEMS) to construct small devices. These techniques allow for control of features down to the submicron level, enabling the production of mechanical structures on scales ranging from <100 nm to >1 cm.

Applications to Ophthalmology

Nanomedicine is fostering revolutionary advances in the diagnosis and treatment of disease, with major effects on biopharmaceuticals, implantable materials, implantable devices, and diagnostic tools. Nanoparticles are colloidal carrier systems that can improve drug delivery efficacy by overcoming diffusion barriers, permitting reduced dosing, and sustaining delivery. Dendrimers, synthetic highly branched polymers with precisely controllable nanoscale scaffolding, have been explored as vehicles for controlled drug delivery, including pilocarpine and gatifloxacin. Cerium oxide (CeO2) nanoparticles (nanoceria) in a vacancy-engineered mixed-valence state can scavenge reactive oxygen intermediates. Intravitreal injection of nanoceria prevents light-induced photoreceptor damage in rodents and inhibits pathologic retinal neovascularization in the Vldlr knockout mouse model, even after mutant retinal phenotypes are established.

Gene Therapy With Nonviral Vectors

Nonviral vectors, such as polymers and lipids, offer high gene-carrying capacity, low risk for immunogenicity, and relatively low cost. Electrostatic interactions of cationic polymers with negatively charged DNA/RNA molecules result in the condensation of material into particles ranging from 8 to 500 nm in diameter. Complexes of cationic polymers and plasmid DNA, termed polyplexes, can have transfection efficiency comparable with adenoviral vectors. Compacted DNA nanoparticles can be targeted to different tissues in the eye through the selection of an appropriate injection site; for example, intravitreal injection can target the cornea, trabecular meshwork, lens, and inner retina, while subretinal injection can target the outer retina and retinal pigment epithelium (RPE).

Molecular Imaging

Nanoparticles are powerful tools for molecular imaging due to their intrinsic magnetic and optical properties and long circulation time. Iron oxide-based nanomaterials, specifically superparamagnetic iron oxide (SPIO) nanoparticles with diameters ranging from 4 to 20 nm, have been investigated as contrast agents for magnetic resonance imaging (MRI). For computed tomography (CT), nano-sized iodinated agents and gold nanomaterials have been studied. Quantum dots (Qdots), light-emitting nanocrystals (2–10 nm), can be visualized with optical imaging, including optical coherence tomography (OCT), and can be used to monitor the survival, distribution, and differentiation of stem cells in vivo.

Minimally Invasive Physiologic Monitoring

Continuous measurement of critical biophysical properties can provide insight into disease pathogenesis and treatment efficacy. Nano-based intraocular pressure (IOP) monitoring systems, such as wireless contact lenses and piezoresistive IOP sensors implanted into the suprachoroidal space, have been developed. Contact lens biosensors with integrated glucose sensors have been manufactured, exhibiting rapid response time and high sensitivity. Semiconductor nanowires, with diameters <100 nm, are promising for establishing active interfaces with biological systems, potentially monitoring retinal ganglion cell (RGC) survival or photoreceptor/RPE physiology.

Vision Restoration

Retinal prosthetics convert real-time video images into electrical signals transmitted to the retina via a microelectrode array. Optogenetics uses light-sensitive ion channels, such as channelrhodopsin-2 (ChR2) and halorhodopsin (HaloR), to stimulate RGCs. ChR2 converts neurons into cells that respond to light with membrane depolarization, while HaloR acts as a yellow light-activated chloride ion pump. Chemical photoswitch therapy uses small molecules, such as DENAQ, to modulate cellular electrical activity. These molecules can be administered via intravitreal injection and have reversible effects, allowing for potential titration of the dose.

Regenerative Medicine and Surgical Technology

Nanostructured scaffolds, including electrospun nanofibers and self-assembled peptide nanofibers, have been designed for retinal and ocular tissue regeneration. These scaffolds can maintain proper three-dimensional organization, aid in cell delivery, and influence cell behavior. Surgical technology is also advancing, with the development of microfabricated axon surgery platforms and nanotweezers for the manipulation of nanostructures. Femtosecond laser systems allow for the precise manipulation of single cells and individual subcellular structures with minimal collateral damage.

Chỉ số/Kết cụcKết quả theo tài liệu
Kích thước hệ thống nanomedicine<100 nm
Đường kính poly(amidoamine) dendrimer1.5 đến 14.5 nm
Đường kính hạt nanoceria3 đến 5 nm
Kích thước hạt DNA polyplex8 đến 500 nm
Đường kính hạt SPIO4 đến 20 nm
Đường kính hạt Quantum dots2 đến 10 nm
Thời gian bán thải của DENAQ2.1 ngày
Bình luận: Thông tin theo Ryan's Retina, 2022; đối chiếu guideline hiện hành khi áp dụng lâm sàng. Các ứng dụng nanomedicine trong nhãn khoa hiện chủ yếu ở giai đoạn tiền lâm sàng hoặc thử nghiệm sớm. Việc kiểm soát độc tính và phản ứng miễn dịch vẫn là thách thức lớn nhất đối với các hệ thống phân phối thuốc dựa trên hạt nano.
  • Cân nhắc tiềm năng của nanoceria trong điều trị các bệnh lý võng mạc có stress oxy hóa.
  • Theo dõi sự phát triển của các hệ thống theo dõi IOP liên tục không xâm lấn.
  • Cập nhật các tiến bộ trong liệu pháp optogenetics cho bệnh nhân thoái hóa võng mạc.
  • Đánh giá vai trò của các giàn giáo nano (nanoscaffolds) trong cấy ghép tế bào RPE.

Tài liệu tham khảo:

Zarbin, M. A., et al., 2022, Nanomedicine in Ophthalmology, Ryan's Retina, 7th Ed., Vol. 1, Chapter 38, pp. 796-824.

Xem thêm